Amarin Corp Plc (AMRN)

[rafunrafun]

Scripts for week ending August 27, 2021

Overall drug TRx are -0.1% w/w

Vascepa
TRx 79,721; +0.0% (+12) w/w; -12.1% y/y
NRx 36,134; +3.5% (+1,234) w/w; -13.2% y/y
Ref 43,586; -2.7% (-1,222) w/w; -11.2% y/y

Lovaza (Generic & Brand)
TRx 61,572; -0 6% (-350) w/w; -2.3% y/y
NRx 30,153; +0.6% (+170) w/w; -2.5% y/y
Ref 31,419; -1.6% (-519) w/w; -2.1% y/y

Generic Vascepa
TRx 16,756; +1.3% (+216) w/w; As % of total V: 17.4%
NRx 9,672; +6.4% (+583) w/w; As % of total V: 21.1%
Ref 7,084; -4.9% (-367) w/w; As % of total V: 14.0%

Generic Vascepa by Manufacturer
Hikma TRx 11,526 (-493); Generic share 68.8%; Total V share 11.9%
Reddy TRx 5,230 (+709); Generic share 31.2%; Total V share 5.4%